biolution

Coagulation Factor VIII recognised by antibody 

Prev Next
Previous

Topoisomerase with Doxorubicin

medical illustration of Factor VIII (FVIII) is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene. Mutations in this gene result in hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is produced in liver cells and endothelial cells. This protein circulates in the bloodstream in an inactive form, bound to another molecule called von Willebrand factor, until an injury that damages blood vessels occurs.
Next medical animation of Ras is an important signalling integrator downstream of several receptor tyrosine kinases. It’s activity is tightly controlled in all eukaryotic cells, as it determines the rate of proliferation and differentiation. Consequently, aberrant ras activation, either too little or too much might cause severe diseases, including cancer, inflammatory and immunological disorders. In fact in a third of all human cancers one of the three RAS genes is mutated, where they act as prototypic oncogenes.

Mutated RAS Signaling

Factor VIII (FVIII) is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene. Mutations in this gene result in hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is produced in liver cells and endothelial cells. This protein circulates in the bloodstream in an inactive form, bound to another molecule called von Willebrand factor, until an injury that damages blood vessels occurs.

Keywords: Color, 3D, Research, Allergy / Immunology, Biology, Biotechnology, General Medicine, Genetics, Natural Science / Nature, Hemophilia

© biolution GmbH